Koninklijke Philips (PHG) Long-Term Debt Repayments (2009 - 2026)
Koninklijke Philips' (PHG) quarterly Long-Term Debt Repayments came in at -$64.4 million in Q1 2026, up 2.83% year-on-year from -$62.6 million in Q1 2025, and up 90.92% quarter-over-quarter from -$708.9 million in Q4 2025.
Koninklijke Philips (PHG) Long-Term Debt Repayments (2009 - 2026) Analysis & Trends
Koninklijke Philips' Long-Term Debt Repayments history runs 18 years deep, the most recent figure standing at -$64.4 million for Q1 2026.
- On a quarterly basis, Long-Term Debt Repayments rose 2.83% year-over-year to -$64.4 million in Q1 2026; TTM through Mar 2026 was -$1.3 billion, a 4.9% increase from a year earlier, with the FY2023 full-year figure at -$811.3 million, changed N/A from the prior year.
- Long-Term Debt Repayments rose to -$64.4 million in Q1 2026 per PHG's latest filing, from -$708.9 million in the prior quarter.
- Across five years, Long-Term Debt Repayments topped out at -$64.1 million in Q1 2024 and bottomed at -$1.5 billion in Q4 2022.
- The 5-year median for Long-Term Debt Repayments is -$346.0 million (2025), against an average of -$512.1 million.
- Across the five-year window, Long-Term Debt Repayments sank 714.56% in 2022 and jumped 89.74% in 2023, its largest moves.
- Year by year, Long-Term Debt Repayments stood at -$1.5 billion in 2022, then surged by 45.98% to -$811.3 million in 2023, then fell by 0.5% to -$815.3 million in 2024, then climbed by 13.05% to -$708.9 million in 2025, then surged by 90.92% to -$64.4 million in 2026.
- Per Business Quant, the three latest PHG Long-Term Debt Repayments figures stand at -$64.4 million (Q1 2026), -$708.9 million (Q4 2025), and -$346.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.42 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 1.00 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -64.39 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -64.39 Mn |
| Mar 31, 2026 | -64.39 Mn |
| Dec 31, 2025 | -708.90 Mn |
| Dec 31, 2025 | -708.90 Mn |
| Sep 30, 2025 | -346.04 Mn |
| Sep 30, 2025 | -346.04 Mn |
| Jun 30, 2025 | -202.62 Mn |
| Jun 30, 2025 | -202.62 Mn |
| Mar 31, 2025 | -66.27 Mn |
| Mar 31, 2025 | -66.27 Mn |
| Dec 31, 2024 | -815.34 Mn |
| Dec 31, 2024 | -815.34 Mn |
| Sep 30, 2024 | -395.36 Mn |
| Sep 30, 2024 | -395.36 Mn |
| Jun 30, 2024 | -113.07 Mn |
| Jun 30, 2024 | -113.07 Mn |
| Mar 31, 2024 | -64.10 Mn |
| Mar 31, 2024 | -64.10 Mn |
| Dec 31, 2023 | -811.26 Mn |
| Dec 31, 2023 | -811.26 Mn |